Jazz Pharmaceuticals PLC
NASDAQ:JAZZ

Watchlist Manager
Jazz Pharmaceuticals PLC Logo
Jazz Pharmaceuticals PLC
NASDAQ:JAZZ
Watchlist
Price: 127.65 USD -0.07% Market Closed
Market Cap: 7.9B USD
Have any thoughts about
Jazz Pharmaceuticals PLC?
Write Note

Jazz Pharmaceuticals PLC
Net Income (Common)

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Jazz Pharmaceuticals PLC
Net Income (Common) Peer Comparison

Comparables:
PRGO
AVDL
G
GHRS
COPN
OVB

Competitive Net Income (Common) Analysis
Latest Figures & CAGR of Competitors

Company Net Income (Common) CAGR 3Y CAGR 5Y CAGR 10Y
Jazz Pharmaceuticals PLC
NASDAQ:JAZZ
Net Income (Common)
$463.2m
CAGR 3-Years
N/A
CAGR 5-Years
-5%
CAGR 10-Years
31%
Perrigo Company PLC
NYSE:PRGO
Net Income (Common)
-$159.7m
CAGR 3-Years
14%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Avadel Pharmaceuticals PLC
NASDAQ:AVDL
Net Income (Common)
-$106.2m
CAGR 3-Years
-24%
CAGR 5-Years
-1%
CAGR 10-Years
-8%
G
GH Research PLC
NASDAQ:GHRS
Net Income (Common)
-$35.6m
CAGR 3-Years
-329%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Cosmo Pharmaceuticals NV
SIX:COPN
Net Income (Common)
€75.7m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
-1%
Ovoca Bio PLC
LSE:OVB
Net Income (Common)
-€3.6m
CAGR 3-Years
-1%
CAGR 5-Years
-12%
CAGR 10-Years
8%

See Also

What is Jazz Pharmaceuticals PLC's Net Income (Common)?
Net Income (Common)
463.2m USD

Based on the financial report for Sep 30, 2024, Jazz Pharmaceuticals PLC's Net Income (Common) amounts to 463.2m USD.

What is Jazz Pharmaceuticals PLC's Net Income (Common) growth rate?
Net Income (Common) CAGR 10Y
31%

Over the last year, the Net Income (Common) growth was 480%.

Back to Top